Cannabis comp tables as of Oct. 1, 2019
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.
This comp table provides a benchmark for private investors to evaluate existing and future investments and a menu for public investors to peruse.
This comp table provides a benchmark for private investors to evaluate existing and future investments and a menu for public investors to peruse.
Our key expectation for Curaleaf was for the guidance for 2020, as we last noted in our review of the Grassroots Cannabis deal, and Curaleaf did not disappoint.
This comp table provides a benchmark for private investors to evaluate existing and future investments and a menu for public investors to peruse.
This comp table provides a benchmark for private investors to evaluate existing and future investments and a menu for public investors to peruse.